Drug Development in Dementia

Dementia is a progressive, irreversible decline in cognition that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementia has several aetiologias of which Alzheimer’s disease (AD) is the most common. Drug development in AD is based on evolving pathophysiological theory. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signaling, neuroinflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and on-going promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.

    Related Conference of Drug Development in Dementia

    April 24-25, 2025

    6th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    April 29-30, 2025

    11th International Conference on Epilepsy & Treatment

    Barcelona, Spain
    May 12-13, 2025

    39th European Neurology Congress

    London, UK
    July 17-18, 2025

    31st Annual Summit on Neuroscience & Neurological Disorders

    Amsterdam, Netherlands
    July 23-24, 2025

    15th Global Alzheimers Summit

    Paris, France
    July 28-29, 2025

    35th World Congress on Neurology and Neuroscience

    Paris, France
    August 25-26, 2025

    20th Annual Congress on Neuroscience

    Aix-en-Provence, France
    September 04-05, 2025

    10th Annual Neurologists and Neurosurgeons Meet

    Vancouver, Canada
    September 25-26, 2025

    12th Annual congress on Stroke and Neurological Disorders

    Zurich, Switzerland
    October 20-21, 2025

    7th World Brain Congress

    Osaka, Japan
    October 23-24, 2025

    8th Global Congress on Spine and Spinal Disorders

    London, UK
    October 29-30, 2025

    5th Annual Dementia Congress

    Amsterdam, Netherlands
    November 13-14, 2025

    32nd Cognitive Neuroscience Congress

    Bali, Indonesia
    December 04-05, 2025

    17th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands

    Drug Development in Dementia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in